Related Experiment Video
Updated: May 29, 2026

Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production
Published on: March 2, 2014
Matrix protein-specific IgA antibody inhibits measles virus replication by intracellular neutralization
Dihan Zhou1, Yan Zhang, Qiaoli Li
1Mucosal Immunity Research Group, State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, China.
Abstract:
Measles virus (MV) is still an imposing threat to public health. The matrix (M) protein has been shown not only to function as a structure block in the assembled MV virions, but also to regulate viral RNA synthesis, playing an important role in MV's replication and assembly. In the present study, we generated a panel of IgG monoclonal antibodies (MAbs) against M protein and successfully obtained one IgA MAb (5H7) from the IgG panel. Employing the polarized Vero cells grown in the two-chamber transwell model, we investigated whether M-specific 5H7 IgA MAb could suppress MV's replication and assembly. The data presented indicate that, while failing to show the activities of traditional neutralization and immune exclusion, M-specific IgA MAb was able to effectively inhibit viral replication by intracellular neutralization (78%), supporting the notion that the M protein is important for MV assembly and replication and implying that the M protein was an effective target antigen. The data also showed that MV had a long entry and assembly phase during viral replication, providing an extended window for IgA intervention. The colocalization of M proteins and M-specific 5H7 IgA MAbs demonstrated that the intracellular neutralization was due to the direct binding of the M-specific 5H7 IgA MAbs to the M proteins. In summary, the present study has added another example showing that IgA antibodies targeting internal viral antigens could proactively participate in mucosal immune protection by intracellular neutralization and has provided evidence that M protein might be included as a target antigen in future MV vaccine design.
Insights
Measles virus (MV) matrix protein-specific IgA antibodies can block viral replication through intracellular neutralization. This suggests the M protein is a viable target for future MV vaccine development.
Area of Science:
- Virology
- Immunology
- Vaccinology
Background:
- Measles virus (MV) remains a significant public health concern.
- The MV matrix (M) protein is crucial for viral replication and assembly.
- Targeting internal viral proteins with IgA antibodies is a potential strategy for mucosal immunity.
Purpose of the Study:
- To investigate the efficacy of an M protein-specific IgA monoclonal antibody (5H7) in inhibiting MV replication and assembly.
- To explore the potential of the M protein as a target antigen for MV vaccines.
Main Methods:
- Generation of a panel of monoclonal antibodies against MV M protein, including an IgA MAb (5H7).
- Utilized polarized Vero cells in a transwell model to assess IgA MAb activity.
- Investigated viral replication, assembly, and intracellular neutralization via colocalization studies.
Main Results:
- The M-specific IgA MAb (5H7) inhibited MV replication by 78% through intracellular neutralization.
- The antibody did not exhibit traditional neutralization or immune exclusion activities.
- Colocalization confirmed direct binding of IgA MAb to intracellular M proteins.
- MV replication demonstrated a prolonged entry and assembly phase, offering a window for IgA intervention.
Conclusions:
- IgA antibodies targeting internal viral antigens, like the MV M protein, can provide mucosal immune protection via intracellular neutralization.
- The MV M protein is an effective target antigen for therapeutic or vaccine strategies.
- Future MV vaccine design could incorporate the M protein to elicit protective IgA responses.
Related Concept Videos
Respiratory Syncytial Virus Disease
Inhibitors of Virion Maturation and Assembly
Inhibitors of Viral Protein Synthesis
Inhibitors Of Virion Release

